Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Am J Ophthalmol. 2020 Jul 6;220:45–52. doi: 10.1016/j.ajo.2020.07.002

TABLE 4.

Visual Acuity and Visual Field Parameters of Treatment Groups at Baseline and at the Study Endpoint

Treatment
Injection Sponge P value
Visual acuity
 Baseline n = 50 n = 50
 Mean logMAR (95% CI) 0.31 (0.22 to 0.41) 0.36 (0.22 to 0.51) .564
 POM6 n = 38 n = 40
 Mean logMAR (95% CI) 0.39 (0.26 to 0.52) 0.36 (0.23 to 0.49) .726
Visual field
 Baseline n = 50 n = 50
 MD, mean (95% CI) −17.19 (−19.5 to −14.9) −15.87 (−18.4 to −13.4) .446
 PSD, mean (95% CI) 9.4 (8.3 to 10.5) 8.9 (7.9 to 9.9) .501
 POM6 n = 38 n = 40
 MD, mean (95% CI) −17.20 (−19.78 to −14.62) −14.37 (−16.92 to −11.82) .153
 PSD, mean (95% CI) 9.2 (8.2 to 10.3) 8.7 (7.7 to 9.8) .538

CI = confidence interval; logMAR = logarithm of minimal angle of resolution.